Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 329

1.

An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit of intensified treatment regimens.

Schieppati F, Balzarini P, Fisogni S, Re A, Pagani C, Bianchetti N, Micheli L, Passi A, Ferrari S, Maifredi A, Bottelli C, Leopaldo R, Pellegrini W, Facchetti F, Rossi G, Tucci A.

Haematologica. 2019 Aug 8. pii: haematol.2019.223891. doi: 10.3324/haematol.2019.223891. [Epub ahead of print]

2.

REAL-WORD EXPERIENCE WITH DECITABINE AS A FIRST-LINE TREATMENT IN 306 ELDERLY ACUTE MYELOID LEUKAEMIA PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY.

Bocchia M, Candoni A, Borlenghi E, Defina M, Filì C, Cattaneo C, Sammartano V, Fanin R, Sciumè M, Sicuranza A, Imbergamo S, Riva M, Fracchiolla N, Latagliata R, Caizzi E, Mazziotta F, Alunni G, Di Bona E, Crugnola M, Rossi M, Consoli U, Fontanelli G, Greco G, Nadali G, Rotondo F, Todisco E, Bigazzi C, Capochiani E, Molteni A, Bernardi M, Fumagalli M, Rondoni M, Scappini B, Ermacora A, Simonetti F, Gottardi M, Lambertenghi Deliliers D, Michieli MG, Basilico C, Galeone C, Pelucchi C, Rossi G.

Hematol Oncol. 2019 Aug 5. doi: 10.1002/hon.2663. [Epub ahead of print]

PMID:
31385337
3.

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment.

Trojani A, Pungolino E, Dal Molin A, Lodola M, Rossi G, D'Adda M, Perego A, Elena C, Turrini M, Borin L, Bucelli C, Malato S, Carraro MC, Spina F, Latargia ML, Artale S, Spedini P, Anghilieri M, Di Camillo B, Baruzzo G, De Canal G, Iurlo A, Morra E, Cairoli R.

PLoS One. 2019 Jul 18;14(7):e0218444. doi: 10.1371/journal.pone.0218444. eCollection 2019.

4.

Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial.

Magni LR, Carcione A, Ferrari C, Semerari A, Riccardi I, Nicolo' G, Lanfredi M, Pedrini L, Cotelli M, Bocchio L, Pievani M, Gasparotti R, Rossi R; CLIMAMITHE Study group.

BMC Psychiatry. 2019 Jun 24;19(1):195. doi: 10.1186/s12888-019-2127-2.

5.

Follicular lymphomas in vulnerable/older patients.

Tucci A, Rossi G.

Curr Opin Oncol. 2019 Sep;31(5):380-385. doi: 10.1097/CCO.0000000000000555.

PMID:
31233484
6.

Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome.

Cattaneo C, Gramegna D, Malagola M, Pagani C, Borlenghi E, Cerqui E, Passi A, Sciumé M, Bernardi S, Crippa C, Dalceggio D, Carbone C, Pelizzari AM, Re A, Russo D, Rossi G.

Leuk Lymphoma. 2019 May 23:1-7. doi: 10.1080/10428194.2019.1613535. [Epub ahead of print]

PMID:
31120311
7.

What's new in management of bone metastases?

Errani C, Bazzocchi A, Spinnato P, Facchini G, Campanacci L, Rossi G, Mavrogenis AF.

Eur J Orthop Surg Traumatol. 2019 May 14. doi: 10.1007/s00590-019-02446-y. [Epub ahead of print] Review.

PMID:
31089821
8.

Circulating microRNAs and Their Role in Multiple Myeloma.

Federico C, Sacco A, Belotti A, Ribolla R, Cancelli V, Giacomini A, Ronca R, Chiarini M, Imberti L, Marini M, Rossi G, Presta M, Paiva B, Roccaro AM.

Noncoding RNA. 2019 May 2;5(2). pii: E37. doi: 10.3390/ncrna5020037. Review.

9.

Whole-brain microstructural white matter alterations in borderline personality disorder patients.

Quattrini G, Marizzoni M, Magni LR, Magnaldi S, Lanfredi M, Rossi G, Frisoni GB, Pievani M, Rossi R.

Personal Ment Health. 2019 May;13(2):96-106. doi: 10.1002/pmh.1441.

PMID:
30989833
10.

Selective arterial embolization as neoadjuvant treatment in hip pseudotumors.

Tokgöz MA, Sambri A, Rossi G, Bianchi G, Donati DM.

Eklem Hastalik Cerrahisi. 2019 Apr;30(1):17-23. doi: 10.5606/ehc.2019.65011.

11.

Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogues.

Fattizzo B, Pasquale R, Carpenedo M, Cantoni S, Auteri G, Gramegna D, D'Adda M, Napolitano M, Consonni D, Ruggeri M, Siragusa S, Rossi G, Vianelli N, Barcellini W.

Haematologica. 2019 Mar 7. pii: haematol.2019.216804. doi: 10.3324/haematol.2019.216804. [Epub ahead of print]

12.

Implications of atrial volumes in surgical corrected Tetralogy of Fallot on clinical adverse events.

Ait Ali L, Lurz P, Ripoli A, Rossi G, Kister T, Aquaro GD, Passino C, Bonhoeffer P, Festa P.

Int J Cardiol. 2019 May 15;283:107-111. doi: 10.1016/j.ijcard.2019.02.018. Epub 2019 Feb 11.

PMID:
30819586
13.

Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management.

Girmenia C, Busca A, Candoni A, Cesaro S, Luppi M, Nosari AM, Pagano L, Rossi G, Venditti A, Aversa F.

Med Mycol. 2019 Apr 1;57(Supplement_2):S127-S137. doi: 10.1093/mmy/myy091.

PMID:
30816979
14.

Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL).

Rusconi C, Anastasia A, Chiarenza A, Marcheselli L, Cavallo F, Rattotti S, Botto B, Ferrari A, Nassi L, Pagani C, Meli E, Arcaini L, Federico M, Rossi G; Fondazione Italiana Linfomi (FIL).

Br J Haematol. 2019 May;185(4):713-717. doi: 10.1111/bjh.15816. Epub 2019 Feb 21.

PMID:
30793297
15.

Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia.

Ferrara F, Lessi F, Vitagliano O, Birkenghi E, Rossi G.

Cancers (Basel). 2019 Feb 14;11(2). pii: E224. doi: 10.3390/cancers11020224. Review.

16.

The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.

D'Adda M, Farina M, Schieppati F, Borlenghi E, Bottelli C, Cerqui E, Ferrari S, Gramegna D, Pagani C, Passi A, Maifredi A, Tucci A, Capucci MA, Ruggeri G, Rossi G.

Cancer. 2019 May 15;125(10):1674-1682. doi: 10.1002/cncr.31977. Epub 2019 Feb 1.

PMID:
30707758
17.

Hiv and Lymphoma: from Epidemiology to Clinical Management.

Re A, Cattaneo C, Rossi G.

Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019004. doi: 10.4084/MJHID.2019.004. eCollection 2019. Review.

18.

Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulation.

Quattrini G, Pini L, Pievani M, Magni LR, Lanfredi M, Ferrari C, Boccardi M, Bignotti S, Magnaldi S, Cobelli M, Rillosi L, Beneduce R, Rossi G, Frisoni GB, Rossi R.

Psychiatry Res Neuroimaging. 2019 Jan 30;283:118-124. doi: 10.1016/j.pscychresns.2018.12.010. Epub 2018 Dec 20.

PMID:
30591402
19.

Alexithymia Predicts Attrition and Outcome in Weight-Loss Obesity Treatment.

Altamura M, Porcelli P, Fairfield B, Malerba S, Carnevale R, Balzotti A, Rossi G, Vendemiale G, Bellomo A.

Front Psychol. 2018 Dec 4;9:2432. doi: 10.3389/fpsyg.2018.02432. eCollection 2018.

20.

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group.

Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10.

PMID:
30545780

Supplemental Content

Loading ...
Support Center